Scroll Top
Gain Therapeutics Inc.

Targeting Parkinson Disease “Pathway Abnormalities” With GT-02287: Jonas Hannestad, MD, PhD

NeurologyLive

Oct 06, 2025

Targeting Parkinson Disease “Pathway Abnormalities” With GT-02287: Jonas Hannestad, MD, PhD

Latest Articles

Clear Filters
December 18, 2025
Two Molecules Show Potential in Targeting GCase Activity for Parkinson’s Disease Treatment
https://www.geneonline.com/two-molecules-show-potential-in-targeting-gcase-activity-for-parkinsons-disease-treatment/
Read More
December 13, 2025
AI and Physics-Based Modeling Identifies a New Parkinson’s Disease Drug
https://www.the-scientist.com/ai-and-physics-based-modeling-identifies-a-new-parkinson-s-disease-drug-73851
Read More
October 9, 2025
In the clinic for Oct. 9, 2025
https://www.bioworld.com/articles/724982-in-the-clinic-for-oct-9-2025
Read More